3-39332369-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_005201.4(CCR8):​c.38C>A​(p.Thr13Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

CCR8
NM_005201.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.850
Variant links:
Genes affected
CCR8 (HGNC:1609): (C-C motif chemokine receptor 8) This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. Chemokines and their receptors are important for the migration of various cell types into the inflammatory sites. This receptor protein preferentially expresses in the thymus. I-309, thymus activation-regulated cytokine (TARC) and macrophage inflammatory protein-1 beta (MIP-1 beta) have been identified as ligands of this receptor. Studies of this receptor and its ligands suggested its role in regulation of monocyte chemotaxis and thymic cell apoptosis. More specifically, this receptor may contribute to the proper positioning of activated T cells within the antigenic challenge sites and specialized areas of lymphoid tissues. This gene is located at the chemokine receptor gene cluster region. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12714729).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CCR8NM_005201.4 linkuse as main transcriptc.38C>A p.Thr13Asn missense_variant 2/2 ENST00000326306.5 NP_005192.1 P51685-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CCR8ENST00000326306.5 linkuse as main transcriptc.38C>A p.Thr13Asn missense_variant 2/21 NM_005201.4 ENSP00000326432.4 P51685-1
CCR8ENST00000414803.1 linkuse as main transcriptc.38C>A p.Thr13Asn missense_variant 2/31 ENSP00000390104.1 C9JIP9
ENSG00000287780ENST00000655387.1 linkuse as main transcriptn.370-39419G>T intron_variant

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD3 exomes
AF:
0.00000797
AC:
2
AN:
250914
Hom.:
0
AF XY:
0.0000148
AC XY:
2
AN XY:
135564
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000882
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000479
AC:
7
AN:
1461630
Hom.:
0
Cov.:
31
AF XY:
0.00000688
AC XY:
5
AN XY:
727124
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000540
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
31
ExAC
AF:
0.0000165
AC:
2
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 19, 2022The c.38C>A (p.T13N) alteration is located in exon 2 (coding exon 1) of the CCR8 gene. This alteration results from a C to A substitution at nucleotide position 38, causing the threonine (T) at amino acid position 13 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
7.8
DANN
Benign
0.96
DEOGEN2
Benign
0.10
T;.
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.78
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.38
T;T
M_CAP
Benign
0.0030
T
MetaRNN
Benign
0.13
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;.
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-1.4
N;D
REVEL
Benign
0.12
Sift
Benign
0.20
T;D
Sift4G
Benign
0.30
T;D
Polyphen
0.017
B;.
Vest4
0.34
MutPred
0.41
Loss of glycosylation at T10 (P = 0.0107);Loss of glycosylation at T10 (P = 0.0107);
MVP
0.31
MPC
0.17
ClinPred
0.078
T
GERP RS
4.3
Varity_R
0.16
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs767101395; hg19: chr3-39373860; API